UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Molecular analysis of TCGA breast cancer histologic types

Cell genomics, 2021-12, Vol.1 (3), p.100067, Article 100067

2021

Volltextzugriff (PDF)

Tyrosine kinase receptor transactivation associated to G protein-coupled receptors

Current drug targets, 2010-09, Vol.11 (9), p.1169-1180

2010

Volltextzugriff (PDF)

Biological and Pharmacological Aspects of the NK1-Receptor

BioMed research international, 2015-01, Vol.2015 (2015), p.1-14

2015

Volltextzugriff (PDF)

The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin

PloS one, 2009-03, Vol.4 (3), p.e4728

2009

Volltextzugriff (PDF)

The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation

PloS one, 2015-06, Vol.10 (6), p.e0129661-e0129661

2015

Volltextzugriff (PDF)

B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer

Cell, 2019-11, Vol.179 (5), p.1191-1206.e21

2019

Volltextzugriff (PDF)

Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer

Oncotarget, 2015-04, Vol.6 (12), p.10604-10616

2015

Volltextzugriff (PDF)

Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer

Cells (Basel, Switzerland), 2020-01, Vol.9 (1), p.203

2020

Volltextzugriff (PDF)

Substance P Autocrine Signaling Contributes to Persistent HER2 Activation That Drives Malignant Progression and Drug Resistance in Breast Cancer

Cancer research (Chicago, Ill.), 2013-11, Vol.73 (21), p.6424-6434

2013

Volltextzugriff (PDF)

Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study

NPJ breast cancer, 2022-07, Vol.8 (1), p.83-83, Article 83

2022

Volltextzugriff (PDF)

Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1

Frontiers in immunology, 2023-09, Vol.14, p.1219250-1219250

2023

Volltextzugriff (PDF)

Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2

Journal of cellular physiology, 2012-04, Vol.227 (4), p.1358-1366

2012

Volltextzugriff (PDF)

TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer

European urology, 2016-11, Vol.70 (5), p.709-713

2016

Volltextzugriff (PDF)

Tumor promoting effects of CD95 signaling in chemoresistant cells

Molecular cancer, 2010-06, Vol.9 (1), p.161-161, Article 161

2010

Volltextzugriff (PDF)

Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death

Cancer biology & therapy, 2011-01, Vol.11 (1), p.4-13

2011

Volltextzugriff (PDF)

A multi-omic single-cell landscape of human gynecologic malignancies

Molecular cell, 2021-12, Vol.81 (23), p.4924-4941.e10

2021

Volltextzugriff (PDF)

FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease

The Journal of clinical investigation, 2020-09, Vol.130 (9), p.4871-4887

2020

Volltextzugriff (PDF)

Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors

Clinical cancer research, 2023-12, Vol.29 (23), p.4894-4907

2023

Volltextzugriff (PDF)

Abstract PO4-06-04: Understanding metastasis mixed-treatment responses through genomic analyses

Cancer research (Chicago, Ill.), 2024-05, Vol.84 (9_Supplement), p.PO4-06-04-PO4-06-04

2024

Volltextzugriff (PDF)

Abstract LB253: Crafted experiments to evaluate feature selection methods for single cell RNA-seq data

Cancer research (Chicago, Ill.), 2024-04, Vol.84 (7_Supplement), p.LB253-LB253

2024

Volltextzugriff (PDF)

The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer

International journal of oncology, 2014-10, Vol.45 (4), p.1658-1672

2014

Volltextzugriff (PDF)

Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications

Breast cancer research and treatment, 2020-01, Vol.179 (1), p.185-195

2020

Volltextzugriff (PDF)

Abstract PD4-08: PD4-08 A Novel Single Cell Model of Tamoxifen Response in Primary Human Breast Tumors

Cancer research (Chicago, Ill.), 2023-03, Vol.83 (5_Supplement), p.PD4-08-PD4-08

2023

Volltextzugriff (PDF)

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Nature cancer, 2023-01, Vol.4 (1), p.128

2023

Volltextzugriff (PDF)

Abstract 5754: Determining the regulatory logic of breast cancer cells using single-cell multi-omics

Cancer research (Chicago, Ill.), 2023-04, Vol.83 (7_Supplement), p.5754-5754

2023

Volltextzugriff (PDF)

1 – 25 von 35

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(29)

Publikationsform

Artikel
(35)

Sprache

Englisch
(35)

Erscheinungsjahr

n.n

Thema

Science & Technology
(24)
Life Sciences & Biomedicine
(22)
Humans
(20)
Female
(13)
Oncology
(13)
Breast Cancer
(9)
Cell Line, Tumor
(8)
Aged
(7)
Cell Biology
(7)
Drug Resistance, Neoplasm
(7)
Middle Aged
(7)
Breast Neoplasms - Pathology
(6)
Gene Expression
(6)
Metastasis
(6)
Tumors
(6)
Breast Neoplasms - Genetics
(5)
Breast Neoplasms - Metabolism
(5)
Male
(5)
Receptors, Neurokinin-1 - Metabolism
(5)
Animals
(4)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Cancer Research
(9)
Current Drug Targets
(2)
European Urology
(2)
Oncotarget
(2)
Plos One
(2)
Annals Of Intensive Care
(1)
Biomed Research International
(1)
Breast Cancer Research And Treatment
(1)
Cancer Biology & Therapy
(1)
Cell
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Molecular analysis of TCGA breast cancer histologic types

Tyrosine kinase receptor transactivation associated to G protein-coupled receptors

Biological and Pharmacological Aspects of the NK1-Receptor

The role of MMP7 and its cross-talk with the FAS/FASL system during the acquisition of chemoresistance to oxaliplatin

The Transmodulation of HER2 and EGFR by Substance P in Breast Cancer Cells Requires c-Src and Metalloproteinase Activation

B Cells and T Follicular Helper Cells Mediate Response to Checkpoint Inhibitors in High Mutation Burden Mouse Models of Breast Cancer

Molecular profiling of peripheral blood is associated with circulating tumor cells content and poor survival in metastatic castration-resistant prostate cancer

Androgen Receptor and Its Splicing Variant 7 Expression in Peripheral Blood Mononuclear Cells and in Circulating Tumor Cells in Metastatic Castration-Resistant Prostate Cancer

Substance P Autocrine Signaling Contributes to Persistent HER2 Activation That Drives Malignant Progression and Drug Resistance in Breast Cancer

Molecular signatures of in situ to invasive progression for basal-like breast cancers: An integrated mouse model and human DCIS study

Aminobisphosphonates reactivate the latent reservoir in people living with HIV-1

Targeting of substance P induces cancer cell death and decreases the steady state of EGFR and Her2

TMPRSS2-ERG in Blood and Docetaxel Resistance in Metastatic Castration-resistant Prostate Cancer

Tumor promoting effects of CD95 signaling in chemoresistant cells

Differential regulation of MMP7 in colon cancer cells resistant and sensitive to oxaliplatin-induced cell death

A multi-omic single-cell landscape of human gynecologic malignancies

FGFR4 regulates tumor subtype differentiation in luminal breast cancer and metastatic disease

Tamoxifen Response at Single-Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors

Abstract PO4-06-04: Understanding metastasis mixed-treatment responses through genomic analyses

Abstract LB253: Crafted experiments to evaluate feature selection methods for single cell RNA-seq data

The neurokinin-1 receptor antagonist aprepitant is a promising candidate for the treatment of breast cancer

Bimodal age distribution at diagnosis in breast cancer persists across molecular and genomic classifications

Abstract PD4-08: PD4-08 A Novel Single Cell Model of Tamoxifen Response in Primary Human Breast Tumors

Multiomics in primary and metastatic breast tumors from the AURORA US network finds microenvironment and epigenetic drivers of metastasis

Abstract 5754: Determining the regulatory logic of breast cancer cells using single-cell multi-omics

Suchergebnisse filtern